Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 926

1.

Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease.

Mosca A, Comparcola D, Romito I, Mantovani A, Nobili V, Byrne CD, Alisi A, Targher G.

Liver Int. 2019 Aug 22. doi: 10.1111/liv.14225. [Epub ahead of print]

PMID:
31436362
2.

Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research.

Terry MB, Michels KB, Brody JG, Byrne C, Chen S, Jerry DJ, Malecki KMC, Martin MB, Miller RL, Neuhausen SL, Silk K, Trentham-Dietz A; Breast Cancer and the Environment Research Program (BCERP).

Breast Cancer Res. 2019 Aug 20;21(1):96. doi: 10.1186/s13058-019-1168-2. Review.

4.

Inflammation and breast density among female Chinese immigrants: exploring variations across neighborhoods.

Fang CY, Egleston BL, Byrne C, Bohr GS, Pathak HB, Godwin AK, Siu PT, Tseng M.

Cancer Causes Control. 2019 Aug 7. doi: 10.1007/s10552-019-01206-x. [Epub ahead of print]

PMID:
31392546
5.

Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.

Mantovani A, Bonapace S, Lunardi G, Canali G, Dugo C, Vinco G, Calabria S, Barbieri E, Laaksonen R, Bonnet F, Byrne CD, Targher G.

Diabetes Metab. 2019 Aug 3. pii: S1262-3636(19)30118-1. doi: 10.1016/j.diabet.2019.07.006. [Epub ahead of print]

PMID:
31386900
6.

Photoelectrocatalytic Degradation of Methylene Blue Using ZnO Nanorods Fabricated on Silicon Substrates.

Rosa APPD, Cavalcante RP, Silva TFD, Gozzi F, Byrne C, McGlynn E, Casagrande GA, Oliveira SC, Junior AM.

J Nanosci Nanotechnol. 2020 Feb 1;20(2):1177-1188. doi: 10.1166/jnn.2020.16961.

PMID:
31383118
7.

A loving embrace.

Byrne C.

CJEM. 2019 Aug 1:1-2. doi: 10.1017/cem.2019.372. [Epub ahead of print] No abstract available.

PMID:
31368427
8.

What is in the sac? Littré hernia.

Bains HK, Agostinho N, Hamilton AE, Byrne C.

ANZ J Surg. 2019 Jul 31. doi: 10.1111/ans.15353. [Epub ahead of print] No abstract available.

PMID:
31368169
9.

Introducing an ambulatory PE pathway with no extra resource.

Baird W, Hannah E, Feenan M, Byrne C, Burke M, Dougan J, Haaijer D, Smyth J.

Clin Med (Lond). 2019 Jun;19(Suppl 3):94. doi: 10.7861/clinmedicine.19-3-s94. No abstract available.

PMID:
31345922
10.

Low levels of alcohol consumption, obesity and development of fatty liver with and without evidence of advanced fibrosis.

Chang Y, Ryu S, Kim Y, Cho YK, Sung E, Kim HN, Ahn J, Jung HS, Yun KE, Kim S, Sung KC, Sohn CI, Shin H, Wild SH, Byrne CD.

Hepatology. 2019 Jul 19. doi: 10.1002/hep.30867. [Epub ahead of print]

PMID:
31325180
11.

A Prospective Evaluation of Point of Care Ultrasound Teaching in Switzerland.

Byrne C, Kahl N, Knight B, Lee M, Morley S, Lahham S, Bingisser R, Thompson M, Shniter I, Valdes V, Fox JC.

J Med Ultrasound. 2019 Apr-Jun;27(2):92-96. doi: 10.4103/JMU.JMU_57_18. Epub 2019 Feb 26.

12.

Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.

Nobili V, Mantovani A, Cianfarani S, Alisi A, Mosca A, Sartorelli MR, Maffeis C, Loomba R, Byrne CD, Targher G.

J Hepatol. 2019 Jul 4. pii: S0168-8278(19)30395-2. doi: 10.1016/j.jhep.2019.06.023. [Epub ahead of print]

PMID:
31279904
13.

Increasing primary anastomosis rate over time for the operative management of acute diverticulitis.

Ahmadi N, Howden WB, Ahmadi N, Byrne CM, Young CJ.

ANZ J Surg. 2019 Jul 4. doi: 10.1111/ans.15321. [Epub ahead of print]

PMID:
31272133
14.

Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.

Zusi C, Mantovani A, Olivieri F, Morandi A, Corradi M, Miraglia Del Giudice E, Dauriz M, Valenti L, Byrne CD, Targher G, Maffeis C.

Dig Liver Dis. 2019 Jun 26. pii: S1590-8658(19)30630-9. doi: 10.1016/j.dld.2019.05.029. [Epub ahead of print]

PMID:
31255630
15.

LIFT and BioLIFT: a 10-Year Single-Centre Experience of Treating Complex Fistula-In-Ano With Ligation of Intersphincteric Fistula Tract Procedure With or Without Bio-prosthetic Reinforcement (BioLIFT).

Lau YC, Brown KGM, Cheong J, Byrne C, Lee PJ.

J Gastrointest Surg. 2019 Jun 25. doi: 10.1007/s11605-019-04305-x. [Epub ahead of print]

PMID:
31240556
16.

The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.

Lappano R, Mallet C, Rizzuti B, Grande F, Galli GR, Byrne C, Broutin I, Boudieu L, Eschalier A, Jacquot Y, Maggiolini M.

Cells. 2019 Jun 14;8(6). pii: E590. doi: 10.3390/cells8060590.

17.

The costs of dementia subtypes to California Medicare fee-for-service, 2015.

Chen Y, Wilson L, Kornak J, Dudley RA, Merrilees J, Bonasera SJ, Byrne CM, Lee K, Chiong W, Miller BL, Possin KL.

Alzheimers Dement. 2019 Jul;15(7):899-906. doi: 10.1016/j.jalz.2019.03.015. Epub 2019 Jun 4.

PMID:
31175026
18.

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients.

Sime FB, Byrne CJ, Parker S, Stuart J, Butler J, Starr T, Pandey S, Wallis SC, Lipman J, Roberts JA.

Crit Care. 2019 Jun 6;23(1):205. doi: 10.1186/s13054-019-2483-9.

19.

Caffeine and myocardial perfusion: a clinical perspective.

Byrne C, Pareek M, Kjaer A, Hasbak P.

Eur Heart J Cardiovasc Imaging. 2019 Jul 1;20(7):763-764. doi: 10.1093/ehjci/jez096. No abstract available.

PMID:
31143957
20.

Diagnosis and management of non-alcoholic fatty liver disease.

Jennison E, Patel J, Scorletti E, Byrne CD.

Postgrad Med J. 2019 Jun;95(1124):314-322. doi: 10.1136/postgradmedj-2018-136316. Epub 2019 May 13. Review.

PMID:
31085617
21.

The Authors' Reply.

Byrne C, Kjaer A, Hasbak P.

JACC Cardiovasc Imaging. 2019 May;12(5):946-947. doi: 10.1016/j.jcmg.2019.03.005. No abstract available.

PMID:
31072526
22.

Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis.

Mantovani A, Lonardo A, Vinco G, Zoppini G, Lippi G, Bonora E, Loomba R, Tilg H, Byrne CD, Fabbri L, Targher G.

Diabetes Metab. 2019 May 5. pii: S1262-3636(19)30068-0. doi: 10.1016/j.diabet.2019.04.008. [Epub ahead of print]

PMID:
31067493
23.

Cardiovascular Health Metrics in the Development and Regression of Nonalcoholic Fatty Liver Disease: A Cohort Study.

Jang EH, Chang Y, Ryu S, Kim S, Kim YH, Sung KC, Cho YK, Lee SJ, Shin H, Wild SH, Byrne CD.

J Clin Med. 2019 May 6;8(5). pii: E610. doi: 10.3390/jcm8050610.

24.

Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.

Mantovani A, Turino T, Altomari A, Lonardo A, Zoppini G, Valenti L, Tilg H, Byrne CD, Targher G.

Metabolism. 2019 Jul;96:56-65. doi: 10.1016/j.metabol.2019.04.012. Epub 2019 Apr 29.

PMID:
31047909
25.

Impact of drug burden index on adverse health outcomes in Irish community-dwelling older people: a cohort study.

Byrne CJ, Walsh C, Cahir C, Bennett K.

BMC Geriatr. 2019 Apr 29;19(1):121. doi: 10.1186/s12877-019-1138-7.

26.

Synovial sepsis of unknown origin in the adult Thoroughbred racehorse.

Byrne CA, Lumsden JM, Lang HM, O'Sullivan CB.

Equine Vet J. 2019 Apr 21. doi: 10.1111/evj.13127. [Epub ahead of print]

PMID:
31006125
27.

Race and overall survival in men diagnosed with prostate cancer in the Department of Defense Military Health System, 1990-2010.

Alexander M, Zhu K, Cullen J, Byrne C, Brown D, Shao S, Rusiecki J.

Cancer Causes Control. 2019 Jun;30(6):627-635. doi: 10.1007/s10552-019-01163-5. Epub 2019 Apr 17.

PMID:
30997591
28.

Effects of Inulin Propionate Ester Incorporated into Palatable Food Products on Appetite and Resting Energy Expenditure: A Randomised Crossover Study.

Byrne CS, Chambers ES, Preston T, Tedford C, Brignardello J, Garcia-Perez I, Holmes E, Wallis GA, Morrison DJ, Frost GS.

Nutrients. 2019 Apr 16;11(4). pii: E861. doi: 10.3390/nu11040861.

29.

Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial.

Chambers ES, Byrne CS, Morrison DJ, Murphy KG, Preston T, Tedford C, Garcia-Perez I, Fountana S, Serrano-Contreras JI, Holmes E, Reynolds CJ, Roberts JF, Boyton RJ, Altmann DM, McDonald JAK, Marchesi JR, Akbar AN, Riddell NE, Wallis GA, Frost GS.

Gut. 2019 Aug;68(8):1430-1438. doi: 10.1136/gutjnl-2019-318424. Epub 2019 Apr 10.

30.

Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies.

Dimopoulos MA, Laubach JP, Echeveste Gutierrez MA, Grzasko N, Hofmeister CC, San-Miguel JF, Kumar S, Labotka R, Lu V, Berg D, Byrne C, Teng Z, Liu G, van de Velde H, Richardson PG.

Eur J Haematol. 2019 Jun;102(6):494-503. doi: 10.1111/ejh.13231. Epub 2019 May 8.

PMID:
30943323
31.

Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.

Sung KC, Seo DC, Lee SJ, Lee MY, Wild SH, Byrne CD.

Nutr Metab Cardiovasc Dis. 2019 May;29(5):489-495. doi: 10.1016/j.numecd.2019.01.016. Epub 2019 Feb 7.

PMID:
30940491
32.

Reproducibility of LVEF, LV volumes, and LV mass between Rubidium-82 PET/CT scans in young healthy volunteers using two commercially available software packages.

Byrne C, Kjaer A, Forman JL, Hasbak P.

J Nucl Cardiol. 2019 Mar 27. doi: 10.1007/s12350-019-01698-9. [Epub ahead of print]

PMID:
30919271
33.

Degenerative tears of the posterior horn of the medial meniscus: correlation between MRI findings and outcome following intra-articular steroid/bupivacaine injection of the knee.

Byrne C, Alkhayat A, Bowden D, Murray A, Kavanagh EC, Eustace SJ.

Clin Radiol. 2019 Jun;74(6):488.e1-488.e8. doi: 10.1016/j.crad.2019.02.007. Epub 2019 Mar 23.

PMID:
30914206
34.

Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD.

Targher G, Mantovani A, Alisi A, Mosca A, Panera N, Byrne CD, Nobili V.

Hepatology. 2019 Jul;70(1):142-153. doi: 10.1002/hep.30625. Epub 2019 May 17.

PMID:
30912854
35.
36.

Myocardial infarction with simultaneous anterior and inferior ST-segment elevation.

Kristensen AMD, Amin S, Byrne C, Pareek M.

Clin Case Rep. 2019 Feb 6;7(3):583-584. doi: 10.1002/ccr3.2023. eCollection 2019 Mar.

37.

The evaluation of the repeatability of the 13C-ketoisocaproate breath test for assessing hepatic mitochondrial function.

Afolabi PR, Scorletti E, Calder PC, Byrne CD.

Isotopes Environ Health Stud. 2019 May;55(2):150-160. doi: 10.1080/10256016.2019.1588265. Epub 2019 Mar 18.

PMID:
30880467
38.

Letter: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density-authors' reply.

Targher G, Mantovani A, Dauriz M, Bonnet F, Byrne CD.

Aliment Pharmacol Ther. 2019 Apr;49(7):961-962. doi: 10.1111/apt.15181. No abstract available.

PMID:
30868629
39.

Identifying Adverse Drug Events in Older Community-Dwelling Patients.

Cahir C, Wallace E, Cummins A, Teljeur C, Byrne C, Bennett K, Fahey T.

Ann Fam Med. 2019 Mar;17(2):133-140. doi: 10.1370/afm.2359.

40.

Trans-anal irrigation should be offered to patients with severe bowel dysfunction.

Byrne CM, Sharma A, Telford K.

Br J Gen Pract. 2019 Mar;69(680):136. doi: 10.3399/bjgp19X701573. No abstract available.

PMID:
30819744
41.

Multi-domain analysis of microvascular flow motion dynamics in NAFLD.

Chipperfield AJ, Thanaj M, Scorletti E, Byrne CD, Clough GF.

Microcirculation. 2019 Jul;26(5):e12538. doi: 10.1111/micc.12538. Epub 2019 Mar 26.

PMID:
30803094
42.

Prognosis Versus Diagnosis and Test Accuracy versus Risk Estimation: Exploring the Clinical Application of the HEART Score.

Byrne C, Toarta C, Holt T.

Acad Emerg Med. 2019 Jun;26(6):701-703. doi: 10.1111/acem.13717. Epub 2019 Mar 12. No abstract available.

PMID:
30801827
43.

Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease.

Mantovani A, Zusi C, Sani E, Colecchia A, Lippi G, Zaza GL, Valenti L, Byrne CD, Maffeis C, Bonora E, Targher G.

Diabetes Metab. 2019 Feb 11. pii: S1262-3636(19)30026-6. doi: 10.1016/j.diabet.2019.01.011. [Epub ahead of print]

PMID:
30763699
44.

Fulminant amoebic colitis and septic shock in a returning traveller.

Morris PD, Lee D, Chung KK, Shin JS, Byrne C.

ANZ J Surg. 2019 Jan;89(1-2):E50. doi: 10.1111/ans.14975. No abstract available.

PMID:
30756503
45.

Body Mass Index, Intensive Blood Pressure Management, and Cardiovascular Events in the SPRINT Trial.

Oxlund CS, Pareek M, Rasmussen BSB, Vaduganathan M, Biering-Sørensen T, Byrne C, Almarzooq Z, Olsen MH, Bhatt DL.

Am J Med. 2019 Jul;132(7):840-846. doi: 10.1016/j.amjmed.2019.01.024. Epub 2019 Feb 2.

PMID:
30721655
46.

Complete remission of immunochemotherapy-refractory monomorphic post-transplant lymphoproliferative disorder mediated by endogenous T-cell recovery.

Bishton MJ, Long HM, Dowell AC, Meckiff BJ, Byrne C, Fox CP.

Leuk Lymphoma. 2019 Aug;60(8):2075-2078. doi: 10.1080/10428194.2019.1571203. Epub 2019 Feb 5. No abstract available.

PMID:
30721640
47.

Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis.

Mantovani A, Gatti D, Zoppini G, Lippi G, Bonora E, Byrne CD, Nobili V, Targher G.

Hepatology. 2019 Jan 31. doi: 10.1002/hep.30538. [Epub ahead of print]

PMID:
30706504
48.

Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study.

Song JU, Jang Y, Lim SY, Ryu S, Song WJ, Byrne CD, Sung KC.

PLoS One. 2019 Jan 23;14(1):e0208736. doi: 10.1371/journal.pone.0208736. eCollection 2019.

49.

Dose-Dependent Effect of Caffeine on Adenosine-Induced Myocardial Stress Perfusion in Rubidium-82 Positron-Emission Tomography/Computed Tomography.

Byrne C, Kjaer A, Wissenberg M, Hurry PK, Schmedes A, Forman JL, Hasbak P.

JACC Cardiovasc Imaging. 2019 Jun;12(6):1102-1103. doi: 10.1016/j.jcmg.2018.10.033. Epub 2019 Jan 16. No abstract available.

PMID:
30660543
50.

Pulse Pressure, Cardiovascular Events, and Intensive Blood-Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT).

Pareek M, Vaduganathan M, Biering-Sørensen T, Byrne C, Qamar A, Almarzooq Z, Pandey A, Olsen MH, Bhatt DL.

Am J Med. 2019 Jun;132(6):733-739. doi: 10.1016/j.amjmed.2019.01.001. Epub 2019 Jan 16.

PMID:
30659811

Supplemental Content

Support Center